Mavorixafor (Xolremdi) for individuals with warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)

Genetics in Medicine Open · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles